$CRVS
Corvus Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
CRVS chart
What traders are saying about $CRVS
Latest postsCorvus Pharmaceuticals, Inc. news
- Corvus Pharmaceuticals to present at 2026 Jeffe...
Pluang ·
- Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference in London
Yahoo Finance ·
- A London conference webcast will remain available for 90 days after Corvus presents.
Stock Titan ·
- Corvus Pharmaceuticals Inc (C17.HM) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- Corvus Pharmaceuticals Inc (C17.HM) Seasonal Returns Chart
Yahoo! Finance Canada ·
- Barclays Maintains Corvus Pharmaceuticals(CRVS.US) With Buy Rating, Maintains Target Price $28
Moomoo ·
- Corvus Pharmaceuticals (CRVS) Stock Price, Chart & Analysis
www.debelegger.nl ·
- Corvus Pharmaceuticals, Inc. (CRVS) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- symbol__ Stock Quote Price and Forecast
CNN ·
- Corvus Pharmaceuticals Stock Price Forecast. Should You Buy CRVS?
StockInvest.us ·
- Corvus Pharmaceuticals, Inc. (CRVS) Seasonal returns chart
Yahoo Finance UK ·
- Corvus (CRVS) Q3 2026 Earnings Call Transcript
fool.com ·
Corvus Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$15.3M | -$62.3M | -$27.0M | -$41.3M |
| Diluted EPS | $-0.53 | $-1.02 | $-0.56 | $-0.89 |
| Total assets (year end) | $71.1M | $68.9M | $45.6M | $68.2M |
| Cash and equivalents (year end) | $4.6M | $8.7M | $12.6M | $13.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Corvus Pharmaceuticals, Inc.
- Ticker
- CRVS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1626971
Frequently asked questions
What exchange is Corvus Pharmaceuticals, Inc. listed on?
Corvus Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol CRVS.
What industry is Corvus Pharmaceuticals, Inc. in?
Corvus Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Corvus Pharmaceuticals, Inc. headquartered?
Corvus Pharmaceuticals, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Corvus Pharmaceuticals, Inc.'s fiscal year end?
Corvus Pharmaceuticals, Inc.'s fiscal year ends on December 31.